The investor, which holds roughly 9% of the company, argued that leadership has failed to translate Novavax's vaccine platform into meaningful commercial success.

Activist investor Shah Capital plans to vote against the re-election of board nominees and the executive ​compensation package at Novavax's upcoming annual meeting, renewing pressure for ‌changes at the vaccine maker.

Novavax, Inc. (NASDAQ: NVAX - Get Free Report) saw some unusual options trading on Monday. Stock investors purchased 21,020 call options on the stock. This is an increase of approximately 71% compared to the typical daily volume of 12,273 call options. Institutional Trading of Novavax A number of large investors have recently added to or reduced

In the closing of the recent trading day, Novavax (NVAX) stood at $8.02, denoting a -1.47% move from the preceding trading day.

Novavax, Inc. (NASDAQ: NVAX - Get Free Report) crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $8.28 and traded as high as $8.42. Novavax shares last traded at $8.09, with a volume of 4,148,236 shares trading hands. Analyst Upgrades and Downgrades

The COVID-19 vaccine boom made fortunes almost overnight—and destroyed them just as fast.

Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical Officer Dr. Walker will continue advancing Novavax's R&D efforts with a focus on data generation to facilitate partnering discussions, Matrix adjuvant innovation and advancement of the Company pipeline   GAITHERSBURG, Md., March 30, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development (R&D).

In the most recent trading session, Novavax (NVAX) closed at $8.95, indicating a -4.18% shift from the previous trading day.

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.